Skip to main content
Journal cover image

How can we create precision immunotherapy as standard in breast cancer?

Publication ,  Journal Article
Hartman, ZC
Published in: Expert Rev Anticancer Ther
November 2021

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Expert Rev Anticancer Ther

DOI

EISSN

1744-8328

Publication Date

November 2021

Volume

21

Issue

11

Start / End Page

1179 / 1181

Location

England

Related Subject Headings

  • Oncology & Carcinogenesis
  • Neoplasms
  • Immunotherapy
  • Immunologic Factors
  • Humans
  • Female
  • Cancer Vaccines
  • Breast Neoplasms
  • Antigens, Neoplasm
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hartman, Z. C. (2021). How can we create precision immunotherapy as standard in breast cancer? Expert Rev Anticancer Ther, 21(11), 1179–1181. https://doi.org/10.1080/14737140.2021.1951241
Hartman, Zachary C. “How can we create precision immunotherapy as standard in breast cancer?Expert Rev Anticancer Ther 21, no. 11 (November 2021): 1179–81. https://doi.org/10.1080/14737140.2021.1951241.
Hartman ZC. How can we create precision immunotherapy as standard in breast cancer? Expert Rev Anticancer Ther. 2021 Nov;21(11):1179–81.
Hartman, Zachary C. “How can we create precision immunotherapy as standard in breast cancer?Expert Rev Anticancer Ther, vol. 21, no. 11, Nov. 2021, pp. 1179–81. Pubmed, doi:10.1080/14737140.2021.1951241.
Hartman ZC. How can we create precision immunotherapy as standard in breast cancer? Expert Rev Anticancer Ther. 2021 Nov;21(11):1179–1181.
Journal cover image

Published In

Expert Rev Anticancer Ther

DOI

EISSN

1744-8328

Publication Date

November 2021

Volume

21

Issue

11

Start / End Page

1179 / 1181

Location

England

Related Subject Headings

  • Oncology & Carcinogenesis
  • Neoplasms
  • Immunotherapy
  • Immunologic Factors
  • Humans
  • Female
  • Cancer Vaccines
  • Breast Neoplasms
  • Antigens, Neoplasm
  • 3211 Oncology and carcinogenesis